コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 vide new options for cell-based therapeutics with curative intent.
2 stly for palliation, but have also been used with curative intent.
3 ollicular lymphoma grade 3 should be treated with curative intent.
4 atic resection for pancreatic adenocarcinoma with curative intent.
5 nal gastrinoma and regional nodal metastases with curative intent.
6 th gastric cancer undergo surgical resection with curative intent.
7 disease; 160 patients underwent exploration with curative intent.
8 ve surgery plus intraperitoneal chemotherapy with curative intent.
9 arenchyma who underwent lung transplantation with curative intent.
10 not resectable, and recurrent but resectable with curative intent.
11 Hence, many are treatable with curative intent.
12 y-seven percent of patients were operated on with curative intent.
13 tastases, cervical operation was carried out with curative intent.
14 are amenable to a second surgical procedure with curative intent.
15 hed a role for this operation when performed with curative intent.
16 t operation and 33 (77%) underwent resection with curative intent.
17 152 consecutive patients had P/D performed with curative intent.
18 eted approach to developing novel treatments with curative intent.
19 oma (HL) or aggressive non-HL (ANHL) treated with curative intent.
20 ection to enable accurate pathologic staging with curative intent.
21 T2 status at diagnosis underwent PS or NAT/S with curative intent.
22 thods of treating patients with renal cancer with curative intent.
23 neck cancer receiving radiation therapy (RT) with curative intent.
24 /19%/29% with stage 0/I/II/III) were treated with curative intent.
25 in patients who receive high dose cisplatin with curative intent.
26 although in selected patients it can be done with curative intent.
27 particular attention to effects of therapies with curative intent.
28 managed with nephrectomy, which is performed with curative intent.
29 ative chemotherapy, and 9 (82%) were treated with curative intent.
30 atification for the receipt of any treatment with curative intent.
31 up to four doses, before undergoing surgery with curative intent.
32 2004 and 2020 and underwent external beam RT with curative intent.
33 amination of axillary nodes is not performed with curative intent.
34 for patients with adult-onset cancer treated with curative intent.
35 included patients who received BC treatment with curative intent.
36 n a patient population treated predominantly with curative intent.
37 n the microbiome of CR hosts and enables LBT with curative intent.
38 h Stage IA-IV lung cancer undergoing surgery with curative intent.
39 ly advanced esophageal cancer (LAEC) treated with curative intent.
40 randomized between open and MI esophagectomy with curative intent.
41 duals, with 35 new localized cancers treated with curative intent.
42 nonsurgical local therapy to the liver mass with curative intent.
43 ents after colorectal cancer (CRC) resection with curative intent.
44 are at high risk of recurrence after surgery with curative intent.
45 vival was performed for all patients treated with curative intent.
46 ity after the treatment of colorectal cancer with curative intent.
47 patients with UTUCs after nephroureterectomy with curative intent.
48 concurrent chemoradiotherapy or radiotherapy with curative intent.
49 y, newly diagnosed HIV-cHL should be managed with curative intent.
50 t-line therapy of carboplatin and paclitaxel with curative intent.
51 nt esophageal cancer after initial treatment with curative intent.
52 recurrent esophageal cancer after treatment with curative intent.
53 F-FDG PET or PET/CT after previous treatment with curative intent.
54 h liver metastases undergo hepatic resection with curative intent.
55 , and survival after treatment of recurrence with curative intent.
56 ent resection of an ampullary adenocarcinoma with curative intent.
57 creatic cancer is poor, even after resection with curative intent.
58 diotherapy, bioradiotherapy, or radiotherapy with curative intent.
59 ely identified patients operated on for LMCO with curative intent.
60 studies compared AS with immediate treatment with curative intent.
61 reported comparisons of WW versus treatment with curative intent.
62 osis patients with single, small HCC treated with curative intent.
63 dic surveillance ultrasound who were treated with curative intent.
64 dge to more definitive consolidation therapy with curative intent.
65 adenocarcinoma who underwent pancreatectomy with curative intent.
66 t of 104 HNSCC patients undergoing treatment with curative intent.
67 7 participants with incident HPV-OPC treated with curative intent, 124 had 1 or more posttreatment or
68 Of 801 patients with primary LS resected with curative intent, 369 (46%) presented with well-diff
69 polychemotherapy and/or salvage-radiotherapy with curative intent (42%), and palliative approaches (3
70 tic cancer and enter an era in which surgery with curative intent actually fulfills this goal on a mu
72 ients with comorbidities can undergo therapy with curative intent and achieve successful long-term ou
73 -invasive gallbladder cancer after resection with curative intent and an Eastern Cooperative Oncology
74 resistance exercise during active treatment with curative intent and may recommend preoperative exer
75 tology] endometrial cancer following surgery with curative intent and no evidence of disease postoper
76 have a reasonable fitness level are treated with curative intent and offered induction chemotherapy.
78 atic cancer who were no longer being treated with curative intent (and 87 caregivers) were randomly a
79 that can enable earlier treatment - ideally with curative intent - and thus lead to improved outcome
80 ) were male, 196 (71%) received chemotherapy with curative intent, and 157 (57%) had gastrointestinal
81 uping was available for 150 patients treated with curative intent, and 3-year PRS for sonic hedgehog
83 d by geographical region, previous treatment with curative intent, and administration of mFOLFOX6 whi
84 ncreatic resection, or, less commonly, both) with curative intent, and an Eastern Cooperative Oncolog
85 reast cancer and patients with NSCLC treated with curative intent, and decreased with age for patient
87 ma and high risk of CNS progression, treated with curative-intent anti-CD20-based chemoimmunotherapy,
88 carefully selected men, active surveillance with curative intent appears to be a safe alternative to
90 age I to III colorectal cancer being treated with curative intent at National Cancer Institute (NCI)
91 re generated from patients with OSCC treated with curative intent at Princess Margaret Cancer Centre
92 ts diagnosed with LRRC who underwent surgery with curative intent at the Catharina Hospital Eindhoven
93 dominantly early-stage breast cancer treated with curative intent at the Princess Margaret Cancer Cen
94 enrolled in the study and those not treated with curative intent at the time of bloodstream infectio
95 dered for surgery or definitive radiotherapy with curative intent before PET/CT was entered into a pr
96 ients who underwent liver resection for MCRC with curative intent between 1991 and 2002 were reviewed
97 went esophagectomy or gastrectomy for cancer with curative intent between 2011 and 2016 and were regi
98 histologically proven HNSCC who were treated with curative intent between January 1, 2006, and Decemb
99 histologically proven HNSCC who were treated with curative intent between January 1, 2006, and Decemb
100 definitive radiotherapy or chemoradiotherapy with curative intent between January 2011 and December 2
101 l cancers are treated with chemoradiotherapy with curative intent but at the consequence of adverse e
102 val in patients undergoing surgery for NSCLC with curative intent, but many of these claims are uncon
103 ng cost-effective, 72%) for patients treated with curative intent, but remained negative for patients
104 Of 63 patients with prostate cancer treated with curative intent by a single radiation oncologist be
105 genes in patients with stage I NSCLC treated with curative intent by means of surgery is associated w
110 sed rate of surgical treatment of recurrence with curative intent compared with minimal follow-up; th
112 ctomy and 5947 (36%) undergoing radiotherapy with curative intent (cT1-3, cM0) and PSA follow-up in S
114 tage tumors were more likely to be treatable with curative intent (Dukes' A: 13/26, 50%; Dukes' B: 32
115 up comprised 2,976 patients who were treated with curative intent either by laparoscopic gastrectomy
116 eristics of patients who underwent resection with curative intent for ductal adenocarcinoma of the pa
118 n is the standard-of-care treatment modality with curative intent for early-stage nonresectable HCC,
119 best currently available therapeutic option with curative intent for fit patients with unfavorable g
120 Surgical resection is the only treatment with curative intent for GBC but very few cases are suit
123 py during the course of treatment, delivered with curative intent for local tumor control or as part
125 nts, treated with radical prostatectomy (RP) with curative intent for PCa who showed rising PSA level
126 median age 62 years) who underwent resection with curative intent for small HCC was identified from a
127 operative PET/CT scan and surgical resection with curative intent from 2001 to 2009 were identified f
128 18 years) with rectal adenocarcinoma managed with curative intent from 2006 to 2020 in the National C
129 nts undergoing multimodal therapy or surgery with curative intent from 2006 to mid-2013 were studied.
130 Of 521 patients who underwent treatment with curative intent from July 1, 2002, to June 30, 2006
132 l carcinoma, were not candidates for surgery with curative intent, had measurable disease, had an est
134 agnosed during surveillance who were treated with curative intent (hepatic resection, liver transplan
135 cell lung cancer (NSCLC) following treatment with curative intent holds promise to identify patients
136 was generally less effective than treatment with curative intent; however, applicability to contempo
137 splantation is at present the only treatment with curative intent; however, the selection of patients
138 tant metastases warrant therapy administered with curative intent, ie, combined-modality therapy cons
139 he CRITICS trial who underwent a gastrectomy with curative intent in a Dutch hospital were included i
141 postresectional CA 19-9 levels after surgery with curative intent in patients with pancreatic cancer.
142 erence in the percentage of patients treated with curative intent in the CEA group was 4.4% (95% CI,
143 the basis of these data, active surveillance with curative intent, in which active treatment is delay
144 olved challenges for the optimal use of ICIs with curative intent include concerns about their applic
145 odels indicated incidence rates of treatment with curative intent increased 17.6% per year during 200
146 A total of 39 patients (52%) were treated with curative intent (induction +/- HCT) and had a 2-y O
147 lottic cancers from 2002 to 2018 and treated with curative intent intensity-modulated radiotherapy (I
148 ents with head and neck cancer (HNC) treated with curative-intent intensity-modulated radiation thera
149 ead and neck squamous cell carcinoma treated with curative-intent intensity-modulated radiation thera
151 Improved survival after a complete resection with curative intent is often predicted by good performa
152 on among older adults and surgical resection with curative intent is the primary treatment of CRC.
154 nts undergoing surgery for colorectal cancer with curative intent (January 2008-March 2012) were incl
157 ority of patients with rectal cancer treated with curative-intent neoadjuvant chemoradiotherapy do no
158 s from GC who were treated with complete CRS with curative intent (no residual nodules > 2.5 mm) at 1
159 HNSCC treated at a specialist cancer centre with curative-intent non-surgical treatment who underwen
160 (P = .0019); for patients treated surgically with curative intent, only risk group predicted CFS (P =
161 ited stage cancer ( P = .035), those treated with curative intent ( P = .003), and those with a lower
162 ies have provided better therapeutic options with curative intent potential for some locoregional the
164 very 3 weeks, both administered concurrently with curative intent radiotherapy in patients with LAHNS
165 , and/or 2-3 high-risk features) and treated with curative-intent radiotherapy and androgen deprivati
166 advanced head and neck cancer (HNC) treated with curative intent remain disappointing, with 5-year s
170 atients >=18 years of age with PMBCL treated with curative intent rituximab-chemotherapy were identif
171 691 men with prostate adenocarcinoma treated with curative-intent RT between 1988 and 2006 were retro
172 male) with bulky node-positive HNSCC treated with curative-intent RT from January 2015 to October 201
173 outcome was surgical treatment of recurrence with curative intent; secondary outcomes were mortality
174 High-dose hematopoietic stem-cell therapies with curative intent should be considered as standard th
176 Tissue microarrays from 145 patients treated with curative intent showed HGAL staining in 75% and was
178 ), radiotherapy (RT), or both (CRT) compared with curative-intent surgery alone for resected BTC were
180 ncer care: during treatment, after treatment with curative intent (survivorship), and after diagnosis
181 atients with acute myeloid leukaemia treated with curative intent, the detection of measurable residu
182 osed between 1995 and 2008, were not treated with curative intent therapy, and received follow-up thr
183 mical recurrence after primary PCa treatment with curative intent, three or fewer extracranial metast
184 biochemical relapse after radical treatment with curative intent to a lethal castrate-resistant meta
186 he basis of radiographic images were treated with curative intent using a multimodality approach invo
187 vival (PRS) were conducted for those treated with curative intent using propensity score analyses to
188 ncidence of cancer; the receipt of treatment with curative intent, using logistic regression adjusted
190 study of patients with breast cancer treated with curative intent was performed at a tertiary academi
193 The 3-year PRS, for 294 patients treated with curative intent, was 52.4% (95% CI, 46.4 to 58.3) w
194 he head and neck who were treated surgically with curative intent were enrolled in our prospective mu
195 ctionated radiation therapy (>=15 fractions) with curative intent were enrolled via convenience sampl
196 t surgery for exocrine pancreatic malignancy with curative intent were identified from a prospective
198 ewly diagnosed from 2000 to 2012 and treated with curative intent were included from the United State
199 ible for adjuvant chemotherapy after surgery with curative intent were included in our double-blind p
200 patients with biliary tract cancer resected with curative intent were randomly assigned to the capec
201 ere enrolled; 223 patients with BTC resected with curative intent were randomly assigned to the capec
203 ould be amenable to additional local therapy with curative intent, whereas metastatic disease would r
204 are administered for a fixed duration, often with curative intent, whereas others are administered ch
205 rcinoma and who underwent surgical resection with curative intent while residing in one of the 11 Sur
206 n or equal to 16 years old who were admitted with curative intent who did not regularly receive dialy
207 cell lung cancer (NSCLC) who undergo surgery with curative intent will relapse within 5 years(1,2).
208 (NPC) are primarily treated by radiotherapy with curative intent with or without chemotherapy and of
209 carcinoma of the glottic larynx were treated with curative intent with radiotherapy alone (73 patient
211 patients are eligible for surgical resection with curative intent, with 5-year overall survival of le
212 % CI, 4.6%-7.2%) were treated for recurrence with curative intent, with little difference according t
213 n a patient population predominantly treated with curative intent, without increasing hospital worklo